F18.951 Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations

Name of the Condition

• Common Name: Inhalant Use Disorder with Psychotic Features
• Medical Term: Inhalant Use, Unspecified with Inhalant-Induced Psychotic Disorder with Hallucinations

Summary

Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations is a mental health condition characterized by the misuse of inhalants—substances that produce chemical vapors—and the development of psychosis, specifically hallucinations. This condition can significantly impact an individual's perception, emotions, and behavior, leading to distorted sensory experiences and impaired functioning.

Causes

Inhalant use disorder is primarily caused by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household items like glue, paint thinner, or aerosols. Genetic predisposition and environmental factors such as socio-economic challenges or peer pressure can also play a role.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Hallucinations (psychotic symptoms).
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.

Diagnosis

Clinical evaluation including a detailed history of inhalant use and psychotic symptoms, physical examination, and assessment of mental status. Laboratory tests may rule out other causes, and diagnostic criteria from manuals like the DSM-5 are typically applied.

Treatment Options

Treatment often involves a combination of psychotherapy, such as cognitive-behavioral therapy, and pharmacotherapy to manage symptoms. Supportive care, including detoxification and rehabilitation programs, may be necessary. Family involvement and long-term follow-up are important.

Prognosis and Follow-Up

Prognosis varies based on the severity of use, presence of co-occurring disorders, and adherence to treatment. Regular follow-up is essential to monitor for relapse, manage symptoms, and adjust treatment plans as needed.

Complications

• Worsening of psychotic symptoms.
• Cognitive impairment or memory problems.
• Physical health issues related to inhalant toxicity.
• Social and occupational dysfunction.

Lifestyle & Prevention

• Avoiding exposure to inhalant products.
• Educating at-risk individuals about the dangers of inhalant use.
• Promoting healthy coping mechanisms and stress management.
• Encouraging open communication with healthcare providers.

When to Seek Professional Help

Seek help if experiencing persistent hallucinations, difficulty controlling inhalant use, or if inhalant use is causing significant distress or impairment in daily life.

Tips for Medical Coders

Document the presence of hallucinations as a key feature of the psychotic disorder. Ensure the diagnosis aligns with clinical criteria and that inhalant use is clearly linked to the psychotic symptoms. Code F18.951 is specific to hallucinations; verify documentation supports this distinction.